Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09GZH
|
||||
Former ID |
DNC008556
|
||||
Drug Name |
(R)-ONDANSETRON
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C18H19N3O
|
||||
Canonical SMILES |
CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
|
||||
InChI |
1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3/t13-/m1/s1
|
||||
InChIKey |
FELGMEQIXOGIFQ-CYBMUJFWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [1] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Voltage gated Potassium channels | ||||
WikiPathways | SIDS Susceptibility Pathways | ||||
Hematopoietic Stem Cell Differentiation | |||||
Potassium Channels | |||||
References | |||||
REF 1 | Bioorg Med Chem. 2008 Apr 1;16(7):4107-19. Epub 2008 Jan 16.A binary QSAR model for classification of hERG potassium channel blockers. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.